Please provide your email address to receive an email when new articles are posted on . Subcutaneous implantable cardioverter defibrillators can prevent arrhythmic death for people with congenital ...

Covenant HealthCare and Dr. Asim Yunus are among the first in Michigan to utilize a new type of implantable defibrillator for patients at risk of sudden cardiac arrest. “This new technology works ...

The Cleveland Clinic announced their team successfully implanted the world's first leadless pacemaker defibrillator system in two patients. Pacemakers provide electrical stimulation to regulate a ...

Electric shocks delivered by subcutaneous defibrillators are equally effective compared to shocks delivered by conventional transvenous defibrillators, according to a study published in the journal ...

The Subcutaneous Implantable Cardioverter‑Defibrillator System Post Approval Study (S‑ICD PAS), which observed patients with subcutaneous implantable cardioverter-defibrillators (S‑ICDs) for 5 years, ...

Please provide your email address to receive an email when new articles are posted on . Subcutaneous implantable cardioverter defibrillators can be extracted safely and feasibly. S-ICD extraction was ...

Medtronic has received U.S. regulatory approval to sell a new implantable defibrillator that can be placed outside of the heart and veins to treat SCA — sudden cardiac arrest — an electrical problem ...

Boston Scientific’s (NYSE:BSX) Cardiac Rhythm Management business accounts for roughly 20% of the company’s value, according to Trefis estimates. It includes products such as pacemakers and ...

The global implantable defibrillator market is projected to grow at a steady CAGR of ~7% during the forecast period, driven by rising cardiovascular disease prevalence, rapid technological innovation, ...

Cleveland Clinic doctors were the first in the world to successfully implant leadless pacemaker defibrillator systems in two patients as part of a global clinical trial sponsored by Boston Scientific, ...